For 20 years, AbbVie’s Humira (adalimumab) was one of the world’s top-selling products, but its patent expiry, and the subsequent entry of biosimilars in January 2023 resulted in a 32% decline ...

ATTENDEE LIST RELEASED – full version is available on the Download Centre of the Pre-Filled Syringes West Coast website. A snap shot of those confirmed attendance: AbbVie, Allergan, Amgen ...